These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3585179)

  • 21. Confusion of apolipoprotein E phenotyping by serum amyloid A.
    Steinmetz A; Saïle R; Sefraoui M; Parra HJ; Fruchart JC
    Clin Chem; 1989 Apr; 35(4):671-2. PubMed ID: 2702754
    [No Abstract]   [Full Text] [Related]  

  • 22. Simple precipitation-based method for the screening of type III hyperlipoproteinemia.
    Nauck M; Glatt L; März W; Feussner G; Wieland H
    Clin Chem; 1999 Jun; 45(6 Pt 1):909-11. PubMed ID: 10352005
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of variant apolipoprotein E by isoelectric focusing and restriction isotyping in a patient with type III hyperlipoproteinemia.
    Nassar BA; McPherson R; Lamothe EM; al-Sultan AI; Zhang ZJ; Rosenblatt DS
    Clin Chem; 1991 Jul; 37(7):1308. PubMed ID: 1677318
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E phenotyping by isoelectric focusing in immobilized pH gradients and silver staining.
    Cartier R; Sassolas A
    Electrophoresis; 1992 Apr; 13(4):252-7. PubMed ID: 1628606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotyping of human apolipoprotein E from whole blood plasma by immunoblotting.
    Steinmetz A
    J Lipid Res; 1987 Nov; 28(11):1364-70. PubMed ID: 3430065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting.
    McDowell IF; Wisdom GB; Trimble ER
    Clin Chem; 1989 Oct; 35(10):2070-3. PubMed ID: 2791274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.
    Janus ED; Grant S; Lintott CJ; Wardell MR
    Atherosclerosis; 1985 Nov; 57(2-3):249-66. PubMed ID: 3866582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia.
    Holmquist L
    Acta Med Scand; 1984; 215(2):113-20. PubMed ID: 6702490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.
    Hirtz C; Vialaret J; Nouadje G; Schraen S; Benlian P; Mary S; Philibert P; Tiers L; Bros P; Delaby C; Gabelle A; Lehmann S
    Clin Chim Acta; 2016 Feb; 454():33-8. PubMed ID: 26707914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia.
    Murase T; Okubo M; Takeuchi I
    J Clin Lipidol; 2010; 4(2):99-104. PubMed ID: 21122636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
    Ghiselli G; Schaefer EJ; Gascon P; Breser HB
    Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isoelectric focusing and immunoblotting identification of human ApoE phenotype].
    Zhang Z; Fan P; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Mar; 29(1):102-4. PubMed ID: 10683994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application.
    Eto M; Watanabe K; Ishii K
    Clin Chim Acta; 1985 Jun; 149(1):21-8. PubMed ID: 4028432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoform patterns of apolipoprotein E in diabetes mellitus.
    Black SC; Hewett S; Kotubi Y; Brunt RV; Reckless JP
    Diabet Med; 1990 Jul; 7(6):532-9. PubMed ID: 2142057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
    Mann WA; Gregg RE; Sprecher DL; Brewer HB
    Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Familial hyperlipoproteinemia type III].
    Yamamura T
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1772-7. PubMed ID: 1479217
    [No Abstract]   [Full Text] [Related]  

  • 38. [Phenotyping of apolipoprotein E: immunoblotting after isoelectric focusing in immobilized pH gradients].
    März W; Cezanne S; Gross W
    Klin Wochenschr; 1990; 68 Suppl 22():113-4. PubMed ID: 2087066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid and simple method for the identification of apolipoprotein E isomorphic phenotypes from whole serum.
    Kohlmeier M; Drossel HJ; Sinha P; Köttgen E
    Electrophoresis; 1992 Apr; 13(4):258-61. PubMed ID: 1378389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.